Hardman Johnston Global Advisors LLC Reduces Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) : vimarsana.com

Hardman Johnston Global Advisors LLC reduced its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 1.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 172,961 shares of the pharmaceutical company’s stock after selling 2,882 shares during the period. Vertex Pharmaceuticals comprises […]

Related Keywords

Canada , Ourania Tatsis , Amit Sachdev , William Blair , News Ratings For Vertex Pharmaceuticals Daily , Vertex Pharmaceuticals Incorporated , Vertex Pharmaceuticals Company Profile , Birch Hill Investment Advisors , Quarter For Vertex Pharmaceuticals , Nasdaq , Vertex Pharmaceuticals , Cassia Capital Partners , Schmidt Pj Investment Management Inc , Newedge Wealth , Royal Bank , Highview Capital Management , Canaccord Genuity Group , Exchange Commission , Vertex Pharmaceuticals Trading Down , Hardman Johnston Global Advisors , Free Report , Johnston Global Advisors , Edge Wealth , Capital Management , Hill Investment Advisors , Capital Partners , Pharmaceuticals Trading Down , Pharmaceuticals Incorporated , Get Free Report , Genuity Group , Vertex Pharmaceuticals Daily , Nasdaq Vrtx , Vrtx , Medical , 92532f10 , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,